BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/18/2025 9:00:44 AM | Browse: 42 | Download: 76
 |
Received |
|
2024-08-21 09:12 |
|
Peer-Review Started |
|
2024-09-05 00:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-01-04 03:27 |
|
Revised |
|
2025-01-12 15:32 |
|
Second Decision |
|
2025-01-18 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-01-18 06:13 |
|
Articles in Press |
|
2025-01-18 06:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-01-19 14:52 |
|
Typeset the Manuscript |
|
2025-01-23 02:49 |
|
Publish the Manuscript Online |
|
2025-02-18 09:00 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jia-Wang Yan, Mei Nie, Hang Zhang, Yan-Miao Liu and Fu-Shan Tang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fu-Shan Tang, PhD, Professor, Department of Clinical Pharmacy, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi 563006, Guizhou Province, China. fstang@vip.163.com |
| Key Words |
Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Combination therapy; Strengths, weaknesses, opportunities, threats analysis |
| Core Tip |
Ongoing advancements in medical research have solidified drug combination therapy as pivotal in the management of inflammatory bowel disease (IBD). This editorial evaluates the current landscape of IBD combination therapy using strengths, weaknesses, opportunities, threats analysis and proposes pathways to enhance the next generation of treatment strategies. |
| Publish Date |
2025-02-18 09:00 |
| Citation |
<p>Yan JW, Nie M, Zhang H, Liu YM, Tang FS. Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease. <i>World J Gastroenterol</i> 2025; 31(9): 100607</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i9/100607.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i9.100607 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
